This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 12/01/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines

Event Date: 12/01/2021
Location: Virtual
Subject: Follow-Up on User Fees
FDA Participant/Group: N/A
Non FDA Participant/Group: David Ricks (Eli Lilly);

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/30/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executive staff and members of the National Association of State Departments of Agriculture

Event Date: 12/01/2021
Location: Virtual
Subject: Panel: The Future of Food Supply Chains, Food Safety Magazine Webinar
FDA Participant/Group: N/A
Non FDA Participant/Group: Food safety experts from industry, academia, and government

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 12/02/2021
Location: Virtual
Subject: Prioritized Activities for 2022 - 2023
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Steering Committee of the Member State Mechanism on Substandard and Falsified Medical Products

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 12/03/2021
Location: Virtual
Subject: Keynote Address: Advancing the Manufacturing of Complex Biologic Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Cedars Sinai Second Annual Symposium on Translational Medicine and Biomanufacturing

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date: 12/02/2021
Location: Virtual
Subject: Update of FDA's Tobacco Products Regulation
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the National Association of Tobacco Outlets (NATO)

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event